Business Daily Media

Business Marketing

.

Eisai: Supplementary New Drug Applications for Anti-Epileptic Drug Fycompa as Monotherapy for Partial-Onset Seizures

  • Written by ACN Newswire - Press Releases

Eisai: Supplementary New Drug Applications for Anti-Epileptic Drug Fycompa as Monotherapy for Partial-Onset Seizures

TOKYO, Oct 16, 2020 - (JCN Newswire) - Eisai Co., Ltd. announced today that the supplementary new drug applications for its in-house discovered and developed anti-epileptic drug (AED) Fycompa (generic name: perampanel) as monotherapy for partial-onset seizures and pediatric indication for partial onset seizures in patients with epilepsy 4 years

Read more //?#

Popular

Shared Company: Benefits Of Using Cloud Software For Your Business

Cloud computing has revolutionized the way businesses operate. By using a cloud, businesses can save time, money, and resources. In this post, we will be discussing the benefits of using a cloud for businesses. We will also b...

A Business Owner's Guide To Trademark Registration

Are you ready to protect your business’ branding by applying for a trademark? Registering a trademark could be an important part of your business. It protects your business’ rights to use the mark to identify your goods and se...

Jennifer Westacott speech to the Department of Foreign Affairs and Trade

After the pandemic, the risk is Australia adopts a mission accomplished mindset – failing to confront the significant challenges ahead of us over the next two decades. To meet these challenges, we’ll need to act differently...

Virtual Office
Tomorrow Business Growth